Cincinnati.com: Patient No. 1 and the cancer trial here that just might change everything

Courtesy of Bexion Pharmaceuticals

BXQ-350, by Bexion Pharmaceuticals of Covington, is a first-of-its-kind cancer treatment, a new approach discovered, developed and tested in Greater Cincinnati. The innovative drug is made from a human protein and does something unlike any other: It weaponizes the special mechanics of cancer to destroy it, without affecting healthy cells.

That the treatment killed nothing but cancer so jarred federal regulators that they had demanded more research in animals. But on a September day in 2016 at the University of Cincinnati’s Barrett Cancer Center, brainpower and money at last brought BXQ-350 to a critical first test for government approval. For more on this story, please go to Cincinnati.com.

Please wait...

Subscribe to the FASTER LANE business newsletter.

Subscribe and receive breaking Kentucky business news and updates daily.